Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (Trehalose free) (MALS verified), Unconjugated 100 ug

Product Overview

• Article Name: Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (Trehalose free) (MALS verified), Unconjugated 100 ug
• Biozol Catalog Number: ABS-S1N-M13A1-100UG
• Supplier Catalog Number: S1N-M13A1-100ug
• Alternative Catalog Number: ABS-S1N-M13A1-100UG
• Manufacturer: AcroBiosystems
• Host: Human
• Category: Antikörper
• Species Reactivity: Mouse
• Conjugation: Unconjugated

Product Description

AntiSARSCoV2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (S1NM13A1) is a chimeric monoclonal antibody combining the constant domains of the human IgG1 molecule with mouse variable regions. The variable region was obtained from a mouse immunized with purified recombinant SARSCoV2 Spike S1 Protein. - Antikörper

Product Properties

• Tag: Human IgG1 | Human Kappa
• Buffer: PBS, pH7.4
• Purity: 0.95
• Form: Liquid
• Target: Spike RBD

Images

Immobilized SARS-CoV-2 S1 protein, His Tag (Cat. No. S1N-C52H2) at 2 µg/mL (100 µL/well) can bind Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (Cat. No. S1N-M13A1) with a linear range of 0.078-1.25 ng/mL (QC tested).

Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) on SDS-PAGE under reducing (R) and under non-reducing (NR) conditions. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 0.95.